426 related articles for article (PubMed ID: 28796922)
1. Long non-coding RNAs and prostate cancer.
Misawa A; Takayama KI; Inoue S
Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
Xu YH; Deng JL; Wang G; Zhu YS
Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
[TBL] [Abstract][Full Text] [Related]
3. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
[TBL] [Abstract][Full Text] [Related]
5. Emerging Roles of Long Non-coding RNAs as Novel Biomarkers in the Diagnosis and Prognosis of Prostate Cancer.
Kan Y; Li B; Yang D; Liu Y; Liu J; Yang C; Mao L
Discov Med; 2021; 32(165):29-37. PubMed ID: 35219354
[TBL] [Abstract][Full Text] [Related]
6. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
Das R; Feng FY; Selth LA
Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
9. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs in prostate cancer: overview and clinical implications.
Malik B; Feng FY
Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
[TBL] [Abstract][Full Text] [Related]
11. [Long non-coding RNAs related to androgen receptor function in prostate cancer: Advances in studies].
Wang M; Ying J; Zhang M; Liang CZ
Zhonghua Nan Ke Xue; 2019 Aug; 25(8):739-743. PubMed ID: 32227719
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer-associated lncRNAs.
Mitobe Y; Takayama KI; Horie-Inoue K; Inoue S
Cancer Lett; 2018 Apr; 418():159-166. PubMed ID: 29330107
[TBL] [Abstract][Full Text] [Related]
14. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.
Wan X; Huang W; Yang S; Zhang Y; Pu H; Fu F; Huang Y; Wu H; Li T; Li Y
Oncotarget; 2016 Sep; 7(37):60503-60518. PubMed ID: 27556357
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment.
Takayama K; Inoue S
Brief Funct Genomics; 2016 May; 15(3):257-65. PubMed ID: 26685282
[TBL] [Abstract][Full Text] [Related]
16. Role of lncRNAs in prostate cancer development and progression.
Weiss M; Plass C; Gerhauser C
Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
[TBL] [Abstract][Full Text] [Related]
17. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.
Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC
Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843
[TBL] [Abstract][Full Text] [Related]
18. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of long non-coding RNA GLIDR in prostate cancer.
Zhang Y; Kong Z; Zhang Y; Huang W; Wu H; Wan X; Li Y
Cancer Biomark; 2017; 19(2):145-150. PubMed ID: 28211799
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?
Deng J; Tang J; Wang G; Zhu YS
Int J Environ Res Public Health; 2017 Mar; 14(3):. PubMed ID: 28272371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
